• 제목/요약/키워드: furosemide

검색결과 113건 처리시간 0.027초

히드록시에칠셀룰로오스를 겔상 메트릭스로 사용한 서방성 푸로세미드정제의 제조 (Preparation of Furosemide Retard Tablets Using Hydroxyethylcellulose as Matrix Forming Material)

  • 김충호;심창구;이민화;김신근
    • Journal of Pharmaceutical Investigation
    • /
    • 제17권2호
    • /
    • pp.47-53
    • /
    • 1987
  • Furosemide retard tablets were prepared using hydroxyethylcellulose(HEC) as a matrix material. Dissolution of furosemide from this tablet was retarded significantly comparing with conventional tablets and greatly dependent on HEC concentration and pH of the dissolution medium. The mechanism of retarded release was supposed to be due to HEC gel formation and drug diffusion through the gel matrix.

  • PDF

W/O/W 삼층막(三層膜) Microcapsules에 관(關)한 연구(硏究) (Three-ply Walled W/O/W Microcapsules Containing Furosemide and Reserpine)

  • 이치호;신영희
    • Journal of Pharmaceutical Investigation
    • /
    • 제14권2호
    • /
    • pp.62-69
    • /
    • 1984
  • Three-ply walled microcapsules containing furosemide and reserpine were prepared from multiple emulsion, and the the appearance of multiple emulsion, the particle size distribution and the drug contents of microcapsules were studied. The microcapsule consisted of alternating three layer of acacia/ethyl cellulose/acacia, and the surface of microcapsules was not porous but wrinkles and had relatively elaborate structure and the particle size range is $4{\mu}m$ to $64{\mu}m$.

  • PDF

개에서 목통(Akebia quinata Decaisne) 추출물의 이뇨효과 평가 (Evaluation of Diuretic and Hemodynamic Effect of Extract from Akebia quinata Decaisne in Dogs)

  • 한숙희;김예원;현창백
    • 한국임상수의학회지
    • /
    • 제29권3호
    • /
    • pp.203-206
    • /
    • 2012
  • 심부전의 치료는 심방의 용적 과부하를 줄이기 위한 이뇨제, 심실 압력 과부하를 줄이기 위한 혈관확장제, 심근의 수축력을 향상시키기 위한 강심제 치료로 이루어진다. 이 중 이뇨제가 개의 심부전 조절에서 가장 중요하다. 하지만 장기간의 이뇨제 사용으로 급성 신부전이나 전해질 이상과 같은 부작용이 발생할 수 있다. 따라서 이 연구는 개에서 부작용이 적으면서 더 나은 이뇨효과를 가지는 생약성분의 이뇨제를 찾기 위해 설계되었다. 5마리의 건강한 개를 대상으로 한 예비실험에서 목통(Akebia quinata Decaisne) 추출물은 경도에서 중등도의 이뇨효과(furosemide 2 mg/kg 용량 효과의 0.3-0.5배의 효력)를 보였으며 혈청화학 수치와 전해질 변동은 거의 없었다. 실험 개체 수가 적고 기간이 충분하지 않지만 이 실험을 통해 심부전 환자에서 furosemide의 사용량을 줄이거나 대체할 수 있는 생약성분의 이뇨제 성분을 발굴하였다.

Cystatin C for managing diuretic-induced kidney dysfunction in MMVD dogs

  • Donghyun Han;Jae Hyeon Cho;Chung Hui Kim
    • 한국동물위생학회지
    • /
    • 제46권3호
    • /
    • pp.181-192
    • /
    • 2023
  • Cystatin C, a low-molecular-weight protein synthesized by cells, is being explored as a valuable biomarker for assessing renal function in veterinary medicine. Although the relationship between cystatin C and heart disease remains unclear, some studies suggest a possible association. This retrospective case-control study aimed to investigate the role of cystatin C as a biomarker for heart disease and its correlation with diuretic use in veterinary clinical practice. A total of 39 dogs were included in this study, comprising 9 control dogs without a predisposition to heart disease and 30 dogs in the study group diagnosed with heart disease. Among the 30 dogs with heart disease, 18 exhibited symptoms indicative of heart failure. Results showed significantly higher cystatin C levels in the heart disease group compared to the control group (P<0.05). However, no significant differences were observed among different stages of heart disease severity in the control group. Furthermore, cystatin-C showed statistically positive correlations with BUN (r=0.478, P<0.01), creatinine (r=0.506, P<0.01), and furosemide (r=0.338, P<0.05). Diuretics are essential for managing congestive heart failure, and the observed associations between cystatin C and furosemide suggest potential impacts of diuretic use on renal function in dogs with heart failure. Monitoring renal function markers, such as cystatin C, can aid in predicting and managing potential renal complications, ultimately improving the overall health and quality of life of dogs with heart disease.

신장청소검사를 이용하여 진단한 Gitelman 증후군 2례 (Two Cases of Gitelman's Syndrome Diagnosed by Renal Clearance Study)

  • 김태화;김승준;서유경;심정연;정혜림;박문수;금동혁
    • Clinical and Experimental Pediatrics
    • /
    • 제45권3호
    • /
    • pp.413-417
    • /
    • 2002
  • 증후군은 원위세뇨관 Na-Cl 공동운반체 유전자 이상으로 발생하는 상염색체 열성 유전질환으로, 저칼륨혈증, 저마그네슘혈증, 대사성 알칼리증, 그리고 저칼슘뇨증 등의 임상적 특징을 보이는 질환이다. 저자들은 Bartter 증후군과의 감별진단과 Gitelman 증후군의 확진을 위해 임상적으로 Gitelman 증후군이 의심되는 두명의 환아에서 신장청소검사를 시행하였다. 각각의 환아는 밤사이 금식을 시킨 후 물 20 mL/kg를 30분에 걸쳐 경구 투여하였고, 곧 이어 half saline을 정맥을 통해 분당 5 mL의 속도로 투여하기 시작하였다. 소변양이 분당 10 mL에 도달했을 때의 검체로 삼투질제거율, 유리수분제거율, 염소제거율, 원위분획염소재흡수율을 계산하였다. 그 후에 첫째 날은 furosemide, 둘째 날은 hydrochlorothiazide를 각각 투여하고 나서 같은 신장청소검사를 시행하였다. 이뇨제를 투여하기 전 원위분획염소재흡수율은 각각 73%, 75%로 정상범위에서 약간 감소되어 있었다. furosemide를 투여한 후 삼투질제거율은 증가하였고 유리수분제거율은 감소하였다. 염소제거율은 10배 이상 증가하였으며, 원위분획염소재흡수율은 현저한 감소를 보였다. Thiazide를 투여한 후에는 위와 같은 청소율의 변화들을 관찰할 수 없었다. 신장청소 검사의 소견은 본 연구의 환아들이 헨레의 고리 상행각의 이상보다는 원위세뇨관 Na-Cl 공동운반체의 이상이 있음을 보여주고 있어 Gitelman 증후군의 병태 생리와 잘 일치한다고 사료된다.

난용성 약물의 용출 증가(제4보) -재결정법에 의한 푸로세미드의 미세화- (Enhancement of Dissolution Properties of Poorly Soluble Drugs(IV) -Micronization of Furosemide by Recrystallization Method-)

  • 고익배;신상철;오인준
    • Journal of Pharmaceutical Investigation
    • /
    • 제18권2호
    • /
    • pp.55-59
    • /
    • 1988
  • The size of furosemide was reduced by the recrystallization method in order to increase the dissolution rate of the drug. Surfactants or hydrophilic polymers were used to suppress the aggregation in the crystal formation-growth process of microparticles by dispersing action. Dissolution rate of microparticles increased remarkably due to the size reduction of microparticle. The particle size decreased with increasing the concentration of the drug and the dispersing agents, i.e., surfactants or hydrophilic polymers. No polymorphic transition occurred during the microcrystallization process, but the habit of crystal formation was altered in the case of anionic surfactant.

  • PDF

저분(猪芬)의 개의 신장기능(腎臟機能)에 미치는 영향(影響) (Effect of Polyporus umbellatus Fries on the Renal Function of Dog)

  • 강형용;고석태
    • Journal of Pharmaceutical Investigation
    • /
    • 제5권1호
    • /
    • pp.28-40
    • /
    • 1975
  • Polyporus would used as diuretics. Then, for the purpose of experimentally certifying the above mention, the effect on the renal function of dog was investigated, utilizing clearance technique. Water and alcohol extracts, when injected intravenously, produced significant increases of urinary sodium and potassium, osmolar and free water clearances, and urine flow, while glomerular filtration rate and renal plasma flow remained unchanged. During diuresis produced by furosemide, addition of water extract reduced the action of furosemide and markedly renal plasma flow. It would appear that these compounds are capable of action by a different mechanism or a different site. water extract, when infused directly into a renal artery, reduced the urine flow of experimental kidney as well as renal plasma flow, and the contralateral kidney exhibited diuresis, whereas amounts of sodium and potassium excreted in urine increased on both kidney. It is surmised from those observations that Polyporus induces diuresis by inhibition the reabsorptive mechanism of renal tubules through some endogeneous humoral substances, in addition, directly reduces the renal plasma flow.

  • PDF

Sodium nitroprusside on acute cardiogenic pulmonary edema in dogs: case reports

  • Han, Mangil;Kim, Yoonhwan;Jeong, Yunho;Ahn, Jin-Ok;Chung, Jin-Young
    • 대한수의학회지
    • /
    • 제62권3호
    • /
    • pp.22.1-22.4
    • /
    • 2022
  • This study reports the efficacy of the vasodilator sodium nitroprusside (SNP), for treatment of acute cardiogenic pulmonary edema in dogs. For this study, the patients were divided into the SNP only treatment group, the SNP, furosemide and dobutamine treatment group, and non-SNP treatment group. Seven dogs, 6 dogs and 2 dogs were favorable responders in SNP only group, group with SNP, furosemide and dobutamine and non-SNP treatment group, each. The results of this study suggest that SNP can be an effective alternative therapy for dogs with acute cardiogenic pulmonary edema.

Diuretic renal scan을 이용(利用)한 폐쇄성(閉鎖性) 요로병변(尿路病變)의 진단(診斷)에 관(關)한 연구(硏究) (A Study on the Effectiveness of Diuretic Renal Scan on Functional and Pathologic Obstructive Uropathy)

  • 안규리;이훈용;권인순;박정식;김성권;이명철;조보연;이정상;고창순;박재형
    • 대한핵의학회지
    • /
    • 제17권2호
    • /
    • pp.57-62
    • /
    • 1983
  • Diuretic renal scan, a modified method of conventional radionuclide renography by administration of intravenous furosemide was performed in 54 patients with suspected urinary tract obstruction. Two showed normal responses, 41 showed increased washout patterns, and the remainder 15 revealed no changes in response to the furosemide administration. IVP was done in 34 patients. In comparision to the diuretic renal scan, the following results were obtained. 1) Patients with normal results by the scan, showed normal IVP findings also. 2) 10 patients who showed delayed excretory patterns not influenced by the diuretics administration. 9 patients revealed obstructive lesions and hydronephrotic changes, and CPN was diagnosed for the remainder one and the one patient without obstruction was diagnosed as chronic pyelonephritis. 3) 22 patients showed positive results to the diuretics. Among them 10 patients had positive results in IVP. but, were not related to the speed of decrement of the renal activity after the furosemide administration.

  • PDF

Effect of anesthetics and diuretics on Doppler measurements of intrarenal resistive index in dogs

  • Choi, Ho-jung;Yoon, Jung-hee;Eom, Ki-dong;Lee, Hee-chon;Choi, Ji-hye;Sung, Jae-ki
    • 대한수의학회지
    • /
    • 제39권4호
    • /
    • pp.832-837
    • /
    • 1999
  • lntrarenal resistive index (RI) was determined in normal, sedated and diuretic kidneys. The mean RI values of normal dogs were $0.64{\pm}0.03$ without statistically significant difference between left and right kidney. Interrenal RI difference (${\Delta}RI$) was $0.03{\pm}0.01$. No significant relationship was found between mean intrarenal RI versus body weight. The mean intrarenal RI values after administration of acepromazine, xylazine, thiopental, and ketamine were $0.66{\pm}0.03$, $0.64{\pm}0.03$, $0.56{\pm}0.05$, and $0.50{\pm}0.05$, respectively. After administration of acepromazine or xylazine, a significant change of the RI was not found. But, a significant decrease of the RI following thiopental or ketamine administration could be observed as compared with the normal RI. The mean intrarenal RI values were $0.63{\pm}0.06$ and $0.62{\pm}0.04$ at 10 minutes and 30 minutes after injection of furosemide, respectively. No significant change of intrarenal RI was found after administration of furosemide. But, mannitol significantly decreased mean intrarenal RI to $0.57{\pm}0.02$ and $0.58{\pm}0.03$ at 30 minutes and 60 minutes, respectively. Based on the obtained results, values of 0.72 and 0.05 may be proposed as the reasonable upper limits of RI and ${\Delta}RI$ of normal average. Acepromazine or xylazine are recommended as anesthetics for renal diseases because they have less effect on the RI. Further study using mannitol injection to increase ${\Delta}RI$ may be suggested in unilateral urinary tract obstruction since mannitol more effectively changed mean RI than furosemide.

  • PDF